Presage Biosciences Announces New Pharma Partnership With AstraZeneca To Evaluate Novel Immuno-Oncology Drug Combinations With CIVO Technology
Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand the complexity of drug response in the tumor microenvironment (TME), has entered